Autopsy report · NCT04036071

Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft

“Business reasons. High subject attrition at the 10-year time point leading to loss of statistical power and data value. Decision finalised: 05May2023.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 years 2 months after it had already started.
• Ran for about 11 years 5 months before it stopped.
• 165 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Smith & Nephew Orthopaedics AG

Sponsor type

Industry

Conditions

Primary Total Hip Arthroplasty

Interventions

Total Hip Arthroplasty

Participants

165

Sites

3

Countries

Austria

Trials that died the same way

• Vitamin D 2 to Dialysis Patients
  “Because of departure of study personnel and lack of funding” (62% match in meaning)
• Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
  “due to financial problems” (60% match in meaning)
• The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients
  “due to organizational reason” (59% match in meaning)
• Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
  “Due to corporate strategic adjustment.” (58% match in meaning)
• Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
  “Due to financial reasons.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.